Training mental health professionals in emotional regulation therapies for alcohol addiction

Dissemination, Acceptability and Adaptation Study of Two Transdiagnostic Psychological Interventions Based on Emotional Regulation (ER) for the Treatment of Alcohol Addiction: Dialectical Behavioral Therapy(DBT) and Unified Protocol (UP)

Not applicable Interventional Universidad de Zaragoza · NCT06366100

This study tests whether training mental health professionals in new therapies can help them better treat people with alcohol addiction in Spain.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment160 (estimated)
Ages18 Years and up
SexAll
SponsorUniversidad de Zaragoza Academic / other
Locations1 site (Teruel, Aragón)
Trial IDNCT06366100 on ClinicalTrials.gov

What this trial studies

This study evaluates the implementation of two transdiagnostic psychological interventions, Dialectical Behavior Therapy for Substance Use Disorders (DBT-SUD) and the Unified Protocol (UP), aimed at treating alcohol addiction within the Spanish National Health System. It focuses on training mental health practitioners and assessing their attitudes towards evidence-based treatments, burnout levels, and readiness to implement these interventions. The study also examines the acceptability and intention to use these therapies in clinical practice after training, as well as various implementation outcomes such as adoption and sustainability.

Who should consider this trial

Good fit: Ideal candidates for this study are mental health professionals, such as psychologists and psychiatrists, currently working in addiction treatment services in Spain.

Not a fit: Patients who are not involved in the treatment of alcohol addiction or do not speak Spanish may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the effectiveness of alcohol addiction treatments by equipping practitioners with advanced emotional regulation strategies.

How similar studies have performed: While research on the implementation of transdiagnostic interventions is emerging, this specific approach has not been extensively tested, making it a novel endeavor.

Eligibility criteria

Show full inclusion / exclusion criteria
Phase 1:

Inclusion Criteria:

* Be at least 18 years of age
* Mental health professional (psychologist, psychiatrist, nurse) currently working in an addiction treatment service
* Agree to receive training in DBT and UP programs
* Understand Spanish
* Accept informed consent

Exclusion Criteria:

* Not being interested in receiving training in emotional regulation interventions
* Not including in their functions, the psychological treatment of people with alcohol addiction
* Not having an Internet connection to be able to connect to the training sessions

Phase 2:

Inclusion criteria:

* Be at least 18 years of age
* Psychologists currently working in an addiction treatment service
* Have received training in DBT and UP interventions in phase 1
* Accept the implementation of any of the 2 interventions and the supervision during the implementation
* Understand the Spanish language
* Accept the informed consent

Exclusion criteria:

* Not being interested in implementing and/or receiving supervision in the interventions
* Not including in their functions, the psychological treatment of people with alcohol addiction
* Not having an Internet connection to be able to connect to the supervision sessions

Where this trial is running

Teruel, Aragón

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Implementation ScienceImplementation scienceAlcohol addictionTransdiagnostic interventionsDialectical Behavior TherapyUnified Protocol
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.